Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors

Journal of Clinical Oncology

Volumn 30, Issue 13, 2012, Pages 1492-1497

  Caan, Bette J ^a   Emond, Jennifer A ^b   Su, H Irene ^b   Patterson, Ruth E ^b   Flatt, Shirley W ^b   Gold, Ellen B ^c   Newman, Vicky A ^b   Rock, Cheryl L ^b   Thomson, Cynthia A ^d   Pierce, John P ^b  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURVIVOR; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; BREAST TUMOR; CANCER STAGING; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SURVIVOR; TIME; TREATMENT OUTCOME; UNITED STATES;

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; EARLY DETECTION OF CANCER; ESTROGEN RECEPTOR MODULATORS; FEMALE; HOT FLASHES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; WEIGHT GAIN; WEIGHT LOSS;

EID: 84862985008     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.36.8597     Document Type: Article

References (38)

1. Carpenter JS, Andrykowski MA, Cordova M, et al: Hot flashes in postmenopausal women treated for breast carcinoma: Prevalence, severity, correlates, management, and relation to quality of life. Cancer 82:1682-1691, 1998 (Pubitemid 28208918)
2. Avis NE, Ory M, Matthews KA, et al: Healthrelated quality of life in a multiethnic sample of middle-aged women: Study of Women's Health Across the Nation (SWAN). Med Care 41:1262-1276, 2003
3. Kravitz HM, Ganz PA, Bromberger J, et al: Sleep difficulty in women at midlife: A community survey of sleep and the menopausal transition. Menopause 10:19-28, 2003 (Pubitemid 36706318)
4. Freeman EW, Sammel MD, Liu L, et al: Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 61:62-70, 2004 (Pubitemid 38044642)
5. Greendale GA, Gold EB: Lifestyle factors: Are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? Am J Med 118:148-154, 2005 (suppl 12B)
6. Sabia S, Fournier A, Mesrine S, et al: Risk factors for onset of menopausal symptoms: Results from a large cohort study. Maturitas 60:108-121, 2008
7. Gold EB, Colvin A, Avis N, et al: Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of women's health across the nation. Am J Public Health 96:1226-1235, 2006 (Pubitemid 43967848)
8. Freedman RR, Krell W: Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol 181:66-70, 1999 (Pubitemid 29343332)
9. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, et al: Hot flashes and subclinical cardiovascular disease: Findings from the Study of Women's Health Across the Nation Heart Study. Circulation 118:1234-1240, 2008
10. Freeman EW, Sammel MD, Grisso JA, et al: Hot flashes in the late reproductive years: Risk factors for Africa American and Caucasian women. J Womens Health Gend Based Med 10:67-76, 2001 (Pubitemid 32229475)
11. Gold EB, Block G, Crawford S, et al: Lifestyle and demographic factors in relation to vasomotor symptoms: Baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol 159:1189-1199, 2004 (Pubitemid 38747266)
12. Thurston RC, Sowers MR, Sutton-Tyrrell K, et al: Abdominal adiposity and hot flashes among midlife women. Menopause 15:429-434, 2008 (Pubitemid 351656746)
13. Thurston RC, Sowers MR, Chang Y, et al: Adiposity and reporting of vasomotor symptoms among midlife women: The study of women's health across the nation. Am J Epidemiol 167:78-85, 2008
14. Whiteman MK, Staropoli CA, Langenberg PW, et al: Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol 101:264-272, 2003 (Pubitemid 36170127)
15. Wilbur J, Miller AM, Montgomery A, et al: Sociodemographic characteristics, biological factors, and symptom reporting in midlife women. Menopause 5:43-51, 1998 (Pubitemid 28257386)
16. Su HI, Sammel MD, Springer E, et al: Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors. Breast Cancer Res Treat 124:205-211, 2010
17. Thurston RC, Sowers MR, Sternfeld B, et al: Gains in body fat and vasomotor symptom reporting over the menopausal transition: The study of women's health across the nation. Am J Epidemiol 170:766-774, 2009
18. Huang AJ, Subak LL, Wing R, et al: An intensive behavioral weight loss intervention and hot flushes in women. Arch Intern Med 170:1161-1167, 2010
19. Caan BJ, Emond JA, Natarajan L, et al: Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat 99:47-57, 2006 (Pubitemid 44168602)
20. Caan BJ, Kwan ML, Hartzell G, et al: Prediagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control 19: 1319-1328, 2008
21. Patterson RE, Cadmus LA, Emond JA, et al: Physical activity, diet, adiposity and female breast cancer prognosis: A review of the epidemiologic literature. Maturitas 66:5-15, 2010
22. Rock CL, Flatt SW, Newman V, et al: Factors associated with weight gain in women after diagnosis of breast cancer: Women's Healthy Eating and Living Study Group. J Am Diet Assoc 99:1212-1221, 1999
23. Saquib N, Flatt SW, Natarajan L, et al: Weight gain and recovery of pre-cancer weight after breast cancer treatments: Evidence from the women's healthy eating and living (WHEL) study. Breast Cancer Res Treat 105:177-186, 2007 (Pubitemid 47366880)
24. Pierce JP, Natarajan L, Caan BJ, et al: Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: The Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 298:289-298, 2007 (Pubitemid 47080483)
25. Matthews KA, Wing RR, Kuller LH, et al: Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med 154:2349-2355, 1994 (Pubitemid 24327854)
26. World Health Organization: Research on the Menopause in the 1990s: Report of WHO Scientific Group. Geneva, Switzerland, World Health Organization, 1996, pp 1-79
27. Bardwell WA, Natarajan L, Dimsdale JE, et al: Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 24:2420-2427, 2006 (Pubitemid 46630617)
28. Wassertheil-Smoller S, Shumaker S, Ockene J, et al: Depression and cardiovascular sequelae in postmenopausal women: The Women's Health Initiative (WHI). Arch Intern Med 164:289-298, 2004 (Pubitemid 38176467)
29. Tuunainen A, Langer RD, Klauber MR, et al: Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview. Psychiatry Res 103:261-270, 2001 (Pubitemid 32817085)
30. Bardwell WA, Major JM, Rock CL, et al: Health-related quality of life in women previously treated for early-stage breast cancer. Psychooncology 13:595-604, 2004
31. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473-483, 1992
32. Hong S, Bardwell WA, Natarajan L, et al: Correlates of physical activity level in breast cancer survivors participating in the Women's Healthy Eating and Living (WHEL) Study. Breast Cancer Res Treat 101:225-232, 2007 (Pubitemid 46115429)
33. Howell A, Cuzick J, Baum M, et al: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer Lancet 365:60-62, 2005
34. Mortimer JE, Flatt SW, Parker BA, et al: Tamoxifen, hot flashes and recurrence in breast cancer. Breast Cancer Res Treat 108:421-426, 2008 (Pubitemid 351431079)
35. Goetz MP, Kamal A, Ames MM: Tamoxifen pharmacogenomics: The role of CYP2D6 as a predictor of drug response. Clin Pharmacol Ther 83:160-166, 2008
36. Demark-Wahnefried W, Peterson BL, Winer EP, et al: Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 19:2381-2389, 2001 (Pubitemid 32391208)
37. Huang AJ, Sawaya GF, Vittinghoff E, et al: Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause 16: 639-643, 2009
38. Miller HG, Li RM: Measuring hot flashes: Summary of a National Institutes of Health workshop. Mayo Clin Proc 79:777-781, 2004 (Pubitemid 38696921)